Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marcell Csanádi
Influence of Biosimilar Infliximab Launch on the Utilization Pattern of Biological Medicines: The Case of Hungary
Expert Review of Pharmacoeconomics and Outcomes Research
Medicine
Health Policy
Pharmacology
Related publications
Biosimilar Medicines: Creating Sustainable Competition in an Era of a New Patent Cliff in Biological Medicines
Journal of Pharmaceutical Policy and Practice
Toxicology
Pharmaceutics
Pharmacology
Health Policy
PF-06438179/GP1111: An Infliximab Biosimilar
BioDrugs
Medicine
Biotechnology
Pharmacology
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
BioDrugs
Medicine
Biotechnology
Pharmacology
Pms69 - Biosimilar and Originator Infliximab: Influence of Local Policy Measures and Practices on Market Dynamics Between Swedish Counties
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
European Medicines Agency Workshop on Biosimilar Monoclonal Antibodies
mAbs
Allergy
Immunology
Efficacious Transition From Reference Infliximab to Biosimilar Infliximab in Clinical Practice
International Journal of Rheumatic Diseases
Rheumatology
Benefits and Drawbacks of Moving to Biosimilar Medicines
Prescriber
Pharmacology
Drug Utilization Pattern of Psychotropic Medicines in Tertiary Care Centre of Bastar Region, Chhattisgarh, India
International Journal of Basic & Clinical Pharmacology
Php184 - Patient Influence on Biosimilar Uptake: The Nocebo Effect
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental